Harrow HROW
NASDAQ HROW
$37.82 -0.03 (-0.08%)
As of: Sep 9, 2026 · 1:44 PM EDT

Harrow (HROW) Non-Current Assets (2010 - 2026)

Harrow (HROW) posted Non-Current Assets of $187.5 million for Q2 2026, down 2.93% on a QoQ basis from $193.2 million in Q1 2026, and down 1.39% year-over-year from $190.1 million in Q2 2025.

Analysis

Harrow (HROW) Non-Current Assets (2010 - 2026) Analysis & Trends

Harrow has reported Non-Current Assets for 16 years, with the latest figure at $187.5 million in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 1.39% year-over-year to $187.5 million in Q2 2026; TTM through Jun 2026 was $753.9 million, a 4.4% decrease from a year earlier, with the FY2025 full-year figure at $187.7 million, down 5.81% from the prior year.
  • Non-Current Assets was $187.5 million for Q2 2026 at Harrow, down from $193.2 million in the prior quarter.
  • The five-year high for Non-Current Assets was $204.5 million in Q3 2024, with the low at $107000.0 in Q4 2022.
  • Average Non-Current Assets over 5 years is $114.3 million, with a median of $171.4 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Assets tumbled 74.03% in 2022, then surged 161285.05% in 2023.
  • Over 5 years, Non-Current Assets stood at $107000.0 in 2022, then soared by 161285.05% to $172.7 million in 2023, then climbed by 15.43% to $199.3 million in 2024, then retreated by 5.81% to $187.7 million in 2025, then decreased by 0.12% to $187.5 million in 2026.
  • The last three Non-Current Assets figures came in at $187.5 million (Q2 2026), $193.2 million (Q1 2026), and $187.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 141.29 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 101.45 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn 94.68 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 159.77 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 113.37 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn - 294.93 Mn
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 1.85 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 3.74 Bn
10 Harrow 1.41 Bn 1.33 Bn 50.36 Mn 187.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187.51 Mn
Mar 31, 2026 193.16 Mn
Dec 31, 2025 187.73 Mn
Sep 30, 2025 185.47 Mn
Jun 30, 2025 190.14 Mn
Mar 31, 2025 194.63 Mn
Dec 31, 2024 199.32 Mn
Sep 30, 2024 204.48 Mn
Jun 30, 2024 167.24 Mn
Mar 31, 2024 170.08 Mn
Dec 31, 2023 172.68 Mn
Sep 30, 2023 780,000.00
Jun 30, 2023 808,000.00
Mar 31, 2023 902,000.00
Dec 31, 2022 107,000.00
Sep 30, 2022 994,000.00
Jun 30, 2022 773,000.00
Mar 31, 2022 411,000.00
Dec 31, 2021 412,000.00
Sep 30, 2021 36,000.00